Valued Advisers Trust Kovitz Core Equity (EQTY) 시세

https://www.stockscores.com/charts/charts/?ticker=sinc

Technically can only buy a percentage of the daily float. I think this was a dump. No additional news and more dumping through the end of the week and this will be well under .001. JMHO

WORLD NEWS -- THE FED JUST WENT BANKRUPT |
Mike Maloney

https://vigilante.tv/lazy-static/thumbnails/65d8e05e-6ccd-4289-8ca8-fa19c60f072a.jpg

https://vigilante.tv/w/wEfP43QVWU9G2gYjRBK9Ab

IMPORTANT: CANCER CURE COVERUP! - Debunking Big Pharma ATTA

Yep, and there have been a few other GREEN DAYS over the last few months also:

https://investorshub.advfn.com/uimage/uploads/2024/10/1/[zxzhNSAV_3_MONTH_SHART.png

But dunno what all the joy is about today. This opened at .0017 and if it wasn't for that last trade for $4

$MLGO needs a .32 break

Best to get them out now below .25

With 4B shares there will always be large blocks to sell.
Sucks for you short term traders.

Let’s make some big money folks! I want everyone to win big!

5001 is by far the most exciting. Obsidian has 2 ongoing Phase 1/2 trials for OBX-115 for melanoma and NSCLC. Iovance will apply for IND to begin Phase 1/2 for IOV-5001 next year.

I’m curious now why they’re working on 3001 since it won’t be much farther along than 5001. 3001 offers i

You're nothing short of awful

Ah, a little light at the end of the tunnel can be seen, let’s hope that they can keep it getting brighter as time passes.

Until they get the codes this stock stuck.

Hilarious.

Sorry, 20+ years in biopharma, I have very good understanding of the basics including FDA Guidelines that NWBO violated repeatedly with protocol revisions, endpoint changes at the last minute, adding new trial arm two weeks before the end of the trial, comparator change that was required BEFORE the

Focused on high grade small scale production, cash flow , acquisition s, paid be cash flow , and plan to take care of not holders

like this

Considering how things are going with the company it stands as a bonus that the shareprice is holding up so well and the abundance of stock naysayers are like voyeurs, living their lies and lives through the experiences here of real retail stock traders....they don't dare do it themselves but prefer

Please keep it off the board.

Once Elite gets all its known planned drugs to market (which will be likely if it has a products with total of $7 billion) its PE ratio will decrease back to average for generic drug industry which is in the 11 range. Its PE is close to justified now at 20ish because they have known approved drugs

cbsnews.com/live will have the debate on streaming live at 9 pm....... Hopefully everyone will watch it......... Especially since Iran has attacked Israel with missiles .. Should be an interesting debate......

Vior Inc. (VIO.v VIORF) has started a fully funded 60,000m drilling campaign @ its Belleterre Gold Project which will focus on 2 key areas, including the Belleterre Mine Trend. Past production at the mine exceeded 750,000 oz @ 10.7 g/t gold. VIO aims to extend mineralization & discover new resources

I could see pros and cons to that question. I personally would let Nasrat bring things up as they become material. He's not going to acknowledge anything that would be considered too "forward looking" anyways.

WORLD GRACE NEWS -- THE FED JUST WENT BANKRUPT |
Mike Maloney

https://vigilante.tv/lazy-static/thumbnails/65d8e05e-6ccd-4289-8ca8-fa19c60f072a.jpg

https://vigilante.tv/w/wEfP43QVWU9G2gYjRBK9Ab

IMPORTANT: CANCER CURE COVERUP! - Debunking Big Pharm

♻️$HCMC amended complaint Presents A Stronger Case🟩$HCWC🟩🟩@healthiercmc

https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/6436df8d94fa09523deadf45/1681317773824/2023-04-12_HCMC_v_PM_Appellate_Decision.pdf


Suf

Agree!!!